SEEK Announces Positive Phase I Data For Universal Flu Vaccine At World Influenza Congress
LONDON, December 8, 2010 /PRNewswire/ -- SEEK, a leading UK privately-owned drug-discovery group, today presented data on the successful conclusion of a Phase I safety and tolerability study for its…